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The replacement of SFAs with unsaturated fatty acids remains
a cornerstone of current dietary guidelines to reduce risk of
atherosclerotic cardiovascular disease (ASCVD) (1). Although
much of the basis for this specific guideline rests on the lowering
of serum LDL cholesterol, there is evidence to suggest that this
dietary exchange may have an impact on other cardiometabolic
risk factors (2, 3). Low serum HDL cholesterol (<40 mg/dL) and
elevated non-HDL cholesterol (>130 mg/dL) are relevant in this
respect, the latter because it represents a measure of cholesterol
in all circulating atherogenic, apoB-containing lipoproteins
[VLDL, IDL, LDL, Lipoprotein (a), and lipoprotein remnants]
(4). The response of serum LDL cholesterol to isoenergetic
macronutrient exchanges has been well documented in meta-
analyses and shown to occur in a dose-response fashion (5, 6);
there is, however, less evidence for the effects of these dietary
exchanges on serum non-HDL cholesterol.
The study by Pinart et al. (7) in this issue of The Journal
of Nutrition reports a study-level meta-analysis (or federated
meta-analysis) in which the analysis was undertaken in each
of the included studies separately, followed by a combination
of all estimates and SEs using conventional study-level meta-
analysis. The dietary exchange model involved the isoenergetic
replacement of 5% of total energy from total carbohydrates
with either total fat, SFAs, PUFAs, or MUFAs. Associations
between these dietary exchanges and serum HDL and non-HDL
cholesterol were examined in 5919 male and female (54%)
participants, aged between 15 and 65 y, from 8 observational
European studies. Five of these studies were longitudinal and
3 cross-sectional, in which data from a baseline or single follow-
up visit were used in the dietary exchange model. The studies,
which were predominantly German (5 of 8) with others from
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Belgium, Italy, and Spain, were part of the European Nutritional
Phenotype Assessment and Data Sharing Initiative. Dietary
intake was assessed by a variety of validated, self-completed
methods that were specific to each country. Data were examined
primarily by virtual individual person data analysis, and a study-
level meta-analysis general linear model to compare results in a
secondary analysis.
In models adjusted for sex, age, smoking, and BMI, the
replacement of carbohydrate with SFAs or PUFAs was shown
to be unrelated to fasted HDL cholesterol, but associated with
a higher and lower non-HDL cholesterol, respectively (SFAs:
1.94 mg/dL; 95% CI: 0.08, 3.79 mg/dL; P = 0.04; and PUFAs:
−3.91 mg/dL; 95% CI: −6.98, −0.84 mg/dL; P = 0.01). In
contrast, replacement of carbohydrate with either total fat or
MUFAs was associated with a higher HDL cholesterol (total
fat: 0.67 mg/dL; 95% CI: 0.40, 0.94 mg/dL; P < 0.0001; and
MUFAs: 0.99 mg/dL; 95% CI: 0.37, 1.60 mg/dL; P = 0.002),
but was unrelated to non-HDL cholesterol. Age was unrelated
to these associations, and there was an inverse association
between non-HDL cholesterol in men and the replacement of
carbohydrate with MUFAs, although substantial heterogeneity
in the data presumably precluded subgroup analysis. The
replacement of 5% of energy from carbohydrates with total fats
was more strongly associated with higher HDL cholesterol in
women (0.84 mg/dL; 95% CI: 0.46, 1.21 mg/dL) than in men
(0.44 mg/dL; 95% CI: 0.07, 0.82 mg/dL; P-interaction = 0.05).
The positive and potentially favorable associations between
the replacement of carbohydrate with total fat or MUFAs
and serum HDL cholesterol are consistent with the established
effects of these dietary exchanges from meta-analyses of
randomized controlled trials (RCTs) (5, 6). The lack of
association between replacing carbohydrate with total fat
and non-HDL cholesterol could suggest that greater emphasis
should be placed on fat quality, rather than quantity, for
reducing cardiometabolic risk. A less consistent result with
previous findings was the absence of significant associations
between carbohydrate replacement with PUFAs or SFAs and
HDL cholesterol. In meta-analyses of RCTs, both LDL and HDL
cholesterol have been reported to show positive associations
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with the addition or removal of dietary PUFAs, MUFAs, and
SFAs with a chain length of 12–16 carbons (5, 6). The lack of
evidence for these associations in this study may reflect a relative
weakness in the modeling of observational data as compared
with that from intervention trials.
The interpretation of what may seem like a counterintuitive
positive association between serum HDL cholesterol and dietary
SFA in meta-analyses of RCTs requires consideration of how
dietary SFA influences the structure and functional properties
of this antiatherogenic lipoprotein. In this respect, associations
between macronutrient exchanges and serum HDL cholesterol
may be of less value in understanding the link between diet,
HDL particles, and ASCVD, in much the same way as the
cholesterol content of LDL particles conveys less information
about LDL atherogenicity than the number and average size of
LDL particles (8). Emerging evidence from studies on the impact
of macronutrient composition on the functional properties of
HDL is beginning to shed light on mechanistic links with
ASCVD (9).
Another point to consider is whether the magnitude of
these statistically significant associations, in terms of higher
and lower non-HDL cholesterol, is of clinical significance to
ASCVD? An increase in non-HDL cholesterol of 1 mg/dL has
been reported to be associated with a 5% increased risk of
coronary artery disease death in men and women with diabetes,
whereas the same change in LDL cholesterol was associated
with a lower, 4% increased risk of coronary artery disease death
(10). Although diabetes is a disease with a high risk of ASCVD,
the higher and lower concentrations of non-HDL cholesterol
associated with the replacement of carbohydrate with SFAs
(+1.94 mg/dL) and PUFAs (−3.91 mg/dL), respectively, give
credibility to the clinical significance of these values.
The study design used carbohydrate as the reference
macronutrient in its isoenergetic exchange models. It also
claimed that the main findings were reproduced when protein
instead of carbohydrate was replaced with dietary fats (data
not shown). Although it is possible to interpret the outcome
of these dietary exchanges in terms of what might happen
when fat is replaced with different fats or carbohydrate, the
isoenergetic replacement of SFAs with PUFAs and/or MUFAs
would have provided more direct evidence to support the
potential benefit of current dietary guidelines to replace SFAs
with unsaturated fats. Moreover, the inclusion of data on serum
LDL cholesterol would have allowed a direct comparison of
the relative efficacy of these dietary exchanges on serum LDL
and non-HDL cholesterol. It would also have been possible
to estimate remnant lipoprotein cholesterol (total cholesterol
minus HDL cholesterol minus LDL cholesterol) as an important
atherogenic component of non-HDL cholesterol (11).
Rigor in the choice and application of statistical methods,
and the harmonization of data across centers, were listed as
major strengths in the present study—in particular, the use of a
remote federated analysis (DataSHIELD), which allowed both
study-level and virtual individual person data meta-analyses,
without the need to pool or share individual-level data. This
approach was reported to offer some advantages by reducing
governance burdens and ethico-legal challenges.
Limitations of the study include the inevitable drawback
of cross-sectional studies producing evidence for associations
between macronutrients and serum lipids, rather than causality.
Outcomes were also subject to residual confounding, and in
coming from just 4 countries may not be representative of
the diverse European population. Perhaps more critically, the
quality and food sources of macronutrients were not assessed
in this study and are known to exert differential effects on
blood lipids and cardiovascular disease risk (12). This includes
the quality of carbohydrates, e.g., whole grains compared with
simple carbohydrates (13), and dietary fats, e.g., n–6 and n–3
PUFAs (14). It also applies to the differential effects of MUFAs
from plants and animals (15), and SFAs from dairy foods and
other animal sources (16).
Notwithstanding these and other methodological limita-
tions, the study by Pinart et al. (7) provides indirect evidence to
support the benefits of replacing dietary SFAs with unsaturated
fats, on serum lipids with greater relevance to cardiometabolic
risk than LDL cholesterol.
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